Ares Life Sciences is an expansion and later stage private equity fund set up by the Bertarelli family with €500 million under management that invests in world class life science companies.
The fund is focused on five specific sectors: Pharmaceuticals, Biotechnology, Diagnostics, Medical Technology and Healthcare services.
Ares Life Sciences aims to add value to its portfolio of companies through a management team that provides exceptional sector experience, investment expertise, scientific knowledge and industry networks.
